Related Experiment Video
Updated: Nov 26, 2025

04:38
Assessment of Sexual Behavior of Male Mice
Published on: March 5, 2020
21.3K
Aplnr knockout mice display sex-specific changes in conditioned fear
Lucas T Laudermilk1, Kathryn M Harper2, Sheryl S Moy2
1Center for Drug Discovery, RTI International, Research Triangle Park, NC, USA.
Behavioural Brain Research
|December 14, 2020
Summary
The apelinergic system, involving APLNR, influences the central nervous system. APLNR knockout mice showed altered fear responses, suggesting potential therapeutic targets for conditions like PTSD.
Area of Science:
- Neuroscience
- Endocrinology
- Pharmacology
Background:
- The apelinergic system, comprising G-protein-coupled receptor APLNR and its ligands, is vital for development and homeostasis.
- APLNR's role in the central nervous system (CNS) remains largely uncharacterized.
- Targeting APLNR is a potential therapeutic strategy for cardiovascular and metabolic diseases.
Purpose of the Study:
- To investigate the function of the apelinergic system within the CNS.
- To elucidate the role of APLNR in sensory, motor, reward, social, learning, memory, and anxiety behaviors.
- To assess the impact of APLNR deficiency on fear-related behaviors.
Main Methods:
- Utilized a knockout mouse model lacking the Aplnr gene.
- Conducted comprehensive behavioral testing, including sensory ability, locomotion, reward and social preference, learning and memory, and anxiety paradigms.
- Analyzed acoustic startle response and conditioned fear responses.
Main Results:
- APLNR knockout significantly affected acoustic startle response.
- Sex-specific alterations in conditioned fear responses were observed in Aplnr knockout mice.
- Male Aplnr knockout mice exhibited heightened context- and cue-dependent fear responses, without changes in baseline anxiety.
Conclusions:
- The APLNR signaling pathway plays a significant role in modulating fear responses within the CNS.
- Findings suggest APLNR's involvement in fear memory and recall.
- Results support further investigation into APLNR-targeted therapies for CNS disorders, particularly PTSD.

